ADIM
ARNC

Alpha DNA Investment Management’s Arconic Corporation ARNC Stock Holding History

Alpha DNA Investment Management’s Portfolio ARNC Stock Details ARNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4
Closed – – 715
2021
Q1 		$0 Buy
4
+2
+100% +$54 ﹤0.01% 804
2020
Q4 		$0 Buy
+2
New +$53 ﹤0.01% 636

Other funds holding ARNC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Alpha DNA Investment Management's ARNC Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Arconic Corporation (ARNC) in Q2 2021, closing a stake of 4 shares.

Alpha DNA Investment Management first reported a position in ARNC in Q4 2020 and held it in 2 quarters. The position peaked at $0 in Q1 2021. 309 funds tracked by Wall St. Rank hold ARNC as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Arconic Corporation position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 4 Arconic Corporation shares in Q2 2021.
  • Alpha DNA Investment Management first reported a position in Arconic Corporation in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Arconic Corporation position peaked at $0 in Q1 2021.
  • 309 funds tracked by Wall St. Rank held Arconic Corporation as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.